NASDAQ:IMPV - Imperva Stock Price, Price Target & More

$49.05 +0.80 (+1.66 %)

(As of 04/27/2018 03:02 AM ET)

Previous Close$49.05

Today's Range$48.25 - $49.20

52-Week Range$37.17 - $52.40

Volume348,593 shs

Average Volume393,359 shs

Market Capitalization$1.71 billion

P/E Ratio-175.18

Dividend YieldN/A

Beta1.67

About Imperva (NASDAQ:IMPV)

Imperva, Inc. engages in the development, market, sale, and support of cyber security solutions that protect business critical data and applications in the cloud or on premises worldwide. The company's SecureSphere product line provides database, file, and Web application security in various data centers, including on-premises data centers, as well as in private, public, and hybrid cloud computing environments. Its SecureSphere product also secures business-critical applications and data; and provides an accelerated route to address regulatory compliance and establishes a repeatable process for data risk management. The company's Incapsula service delivers cloud-based Website security, distributed denial of service protection, and load balancing and failover; and is designed to deploy and accessible to businesses that need to optimize the security, speed, and availability of their Websites. Its products also include ThreatRadar that provides reputation and crowdsourced security intelligence services; CounterBreach, which protects enterprise data from theft and loss due to compromised, malicious, and careless users; and Imperva Camouflage Data Masking that creates functional data for development, testing, and training by disguising sensitive information while maintaining the characteristics of the original data. In addition, the company provides ongoing product support services for hardware and software; and professional and training services. Imperva, Inc. offers its products and services to banks, retailers, insurers, technology and telecommunication companies, and hospitals; and the United States and other national, state, and local government agencies through a network of distributors and resellers. The company was founded in 2002 and is headquartered in Redwood Shores, California.

Receive IMPV News and Ratings via Email

Sign-up to receive the latest news and ratings for IMPV and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Prepackaged software

Sub-IndustrySystems Software

SectorComputer and Technology

SymbolNASDAQ:IMPV

CUSIP45321L10

Webwww.imperva.com

Phone650-345-9000

Debt

Debt-to-Equity RatioN/A

Current Ratio2.71%

Quick Ratio2.70%

Price-To-Earnings

Trailing P/E Ratio-175.18

Forward P/E Ratio1,635.00

P/E Growth56

Sales & Book Value

Annual Sales$321.72 million

Price / Sales5.31

Cash Flow$0.0560 per share

Price / Cash876.28

Book Value$9.26 per share

Price / Book5.30

Profitability

EPS (Most Recent Fiscal Year)($0.28)

Net Income$22.86 million

Net Margins7.11%

Return on Equity-3.28%

Return on Assets-1.94%

Miscellaneous

Employees1,020

Outstanding Shares34,810,000

Imperva (NASDAQ:IMPV) Frequently Asked Questions

What is Imperva's stock symbol?

Imperva trades on the NASDAQ under the ticker symbol "IMPV."

How were Imperva's earnings last quarter?

Imperva (NASDAQ:IMPV) released its quarterly earnings results on Wednesday, May, 2nd. The software maker reported $0.26 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.19 by $0.07. The software maker earned $84.24 million during the quarter, compared to analysts' expectations of $83.77 million. Imperva had a net margin of 7.11% and a negative return on equity of 3.28%. The business's quarterly revenue was up 16.5% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.09 earnings per share. View Imperva's Earnings History.

What price target have analysts set for IMPV?

16 Wall Street analysts have issued 12-month price objectives for Imperva's shares. Their forecasts range from $39.00 to $61.00. On average, they expect Imperva's stock price to reach $53.6154 in the next twelve months. View Analyst Ratings for Imperva.

What are Wall Street analysts saying about Imperva stock?

Here are some recent quotes from research analysts about Imperva stock:

1. According to Zacks Investment Research, "Imperva Inc. is engaged in the development of protection software and services for business applications and databases. The Company delivers innovative technology to give full audit accountability and separation of duties to meet regulatory compliance. It offers SecureSphere Data Security Suite to protect sensitive data from hackers and malicious insiders along with providing a fast and cost-effective route to regulatory compliance and establishes a repeatable process for data risk management. The Company's SecureSphere offers database security solutions to secure sensitive data stored in databases, File Security solutions to protect sensitive files on file servers, storage devices, content repositories, and meet regulatory compliance mandates and Web Application Security solutions to protect web applications from cyber attacks. Imperva Inc. is headquartered in Redwood Shores, California. " (4/11/2018)
2. Evercore ISI analysts commented, "We believe that the quarter was in part helped by the deposition of Skyfence which carried annual operating expenses of ~$25M (and revenue of ~$1M). There is likely a tailwind to margins in 2Q from the deposition as well, despite the company’s ongoing plans to reinvest the savings in growth areas. Management guided to ~7% non-GAAP margins for F17 which compares favorably to consensus of ~5.6% going into the quarter. We continue to believe that the company is working to improve its business but has largely overcome the execution challenges that plagued results last year. We are encouraged by the high level of growth (+64.5% y/y in 1Q17) seen in the company’s subscription offerings which may be further helped by the introduction of FlexProtect which makes form factor (on-prem vs cloud) less relevant. This should offset concerns on the company’s on-premise WAF decline." (5/5/2017)

Are investors shorting Imperva?

Imperva saw a increase in short interest during the month of March. As of March 15th, there was short interest totalling 1,847,957 shares, an increase of 56.0% from the February 28th total of 1,184,332 shares. Based on an average daily trading volume, of 540,724 shares, the days-to-cover ratio is currently 3.4 days. Currently, 5.4% of the shares of the stock are short sold.

Who are some of Imperva's key competitors?

Some companies that are related to Imperva include Tableau Software (DATA), Sina (SINA), Konami (KNMCY), Paycom (PAYC), National Instruments (NATI), Guidewire Software (GWRE), LogMeIn (LOGM), MuleSoft (MULE), Atlassian (TEAM), Blackbaud (BLKB), RealPage (RP), Okta (OKTA), Nuance Communications (NUAN), 2U (TWOU) and Medidata Solutions (MDSO).

Who are Imperva's key executives?

Imperva's management team includes the folowing people:

Ms. Trâm T. Phi, Sr. VP, Gen. Counsel & Corp. Sec. (Age 47)
Mr. Christopher S. Hylen, Pres, CEO & Director (Age 57)
Mr. Michael J. Burns, Chief Financial Officer & Treasurer (Age 52)
Mr. Aharon Strosberg, VP of Operations
Mr. Terry Ray, Chief Technology Officer

Has Imperva been receiving favorable news coverage?

Media headlines about IMPV stock have trended somewhat positive on Friday, Accern Sentiment reports. The research firm scores the sentiment of news coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Imperva earned a coverage optimism score of 0.15 on Accern's scale. They also assigned news coverage about the software maker an impact score of 44.11 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.

How do I buy shares of Imperva?

Shares of IMPV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Imperva's stock price today?

One share of IMPV stock can currently be purchased for approximately $49.05.

How big of a company is Imperva?

Imperva has a market capitalization of $1.71 billion and generates $321.72 million in revenue each year. The software maker earns $22.86 million in net income (profit) each year or ($0.28) on an earnings per share basis. Imperva employs 1,020 workers across the globe.

How can I contact Imperva?

Imperva's mailing address is 3400 BRIDGE PARKWAY SUITE 200, REDWOOD SHORES CA, 94065. The software maker can be reached via phone at 650-345-9000 or via email at [email protected]

MarketBeat Community Rating for Imperva (IMPV)

Community Ranking:		3.3 out of 5 ( )
Outperform Votes:		578 (Vote Outperform)
Underperform Votes:		299 (Vote Underperform)
Total Votes:		877

MarketBeat's community ratings are surveys of what our community members think about Imperva and other stocks. Vote "Outperform" if you believe IMPV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IMPV will underperform the S&P 500 over the long term. You may vote once every thirty days.

Imperva (NASDAQ:IMPV) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

16 Wall Street analysts have issued ratings and price targets for Imperva in the last 12 months. Their average twelve-month price target is $53.6154, suggesting that the stock has a possible upside of 9.31%. The high price target for IMPV is $61.00 and the low price target for IMPV is $39.00. There are currently 2 sell ratings, 4 hold ratings and 10 buy ratings for the stock, resulting in a consensus rating of "Buy."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Buy	Hold	Hold	Buy
Consensus Rating Score:	2.50	2.47	2.41	2.58
Ratings Breakdown:	2 Sell Rating(s) 4 Hold Rating(s) 10 Buy Rating(s) 0 Strong Buy Rating(s)	2 Sell Rating(s) 4 Hold Rating(s) 9 Buy Rating(s) 0 Strong Buy Rating(s)	2 Sell Rating(s) 6 Hold Rating(s) 9 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 8 Hold Rating(s) 11 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$53.6154	$53.00	$52.00	$51.3214
Price Target Upside:	9.31% upside	13.86% upside	24.25% upside	17.98% upside

Imperva (NASDAQ:IMPV) Consensus Price Target History

Price Target History for Imperva (NASDAQ:IMPV)

Imperva (NASDAQ:IMPV) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
4/23/2018	Royal Bank of Canada	Reiterated Rating	Buy	$54.00	Low
4/10/2018	DA Davidson	Initiated Coverage	Buy -> Buy	$56.00	High
2/9/2018	Imperial Capital	Boost Price Target	Outperform -> Outperform	$50.00 -> $55.00	Low
2/9/2018	Morgan Stanley	Boost Price Target	Underweight -> Underweight	$37.00 -> $39.00	High
2/9/2018	Evercore ISI	Set Price Target	Buy	$56.00	High
2/9/2018	Piper Jaffray	Upgrade	Neutral -> Overweight	$52.00	High
12/12/2017	JPMorgan Chase	Downgrade	Neutral -> Underweight	$45.00	High
11/9/2017	Oppenheimer	Reiterated Rating	Buy	$55.00	N/A
11/9/2017	Stifel Nicolaus	Reiterated Rating	Hold -> Hold	$50.00 -> $47.00	N/A
10/24/2017	KeyCorp	Reiterated Rating	Hold		N/A
10/10/2017	William Blair	Downgrade	Outperform -> Market Perform		N/A
10/9/2017	Wells Fargo	Downgrade	Outperform -> Market Perform		N/A
7/28/2017	Monness Crespi & Hardt	Boost Price Target	Buy	$55.00 -> $57.00	High
7/13/2017	Stephens	Reiterated Rating	Overweight	$53.00 -> $61.00	Low
6/7/2017	Susquehanna Bancshares	Initiated Coverage	Positive -> Positive	$60.00	Low
6/6/2017	UBS	Initiated Coverage	Positive	$60.00	N/A
2/9/2017	BTIG Research	Initiated Coverage	Neutral		N/A
11/4/2016	Nomura	Reiterated Rating	Hold	$37.50	N/A
11/4/2016	Needham & Company LLC	Upgrade	Hold -> Buy	$64.00 -> $43.00	N/A
11/4/2016	Macquarie	Upgrade	Neutral -> Outperform		N/A
10/22/2016	Buckingham Research	Reiterated Rating	Neutral	$45.00	N/A
10/15/2016	Deutsche Bank	Reiterated Rating	Hold		N/A
9/25/2016	JMP Securities	Reiterated Rating	Outperform	$50.00 -> $56.00	N/A
9/13/2016	Wunderlich	Initiated Coverage	Hold	$50.00	N/A
8/30/2016	Pacific Crest	Downgrade	Overweight -> Sector Weight	$47.00 -> $30.00	N/A

(Data available from 4/27/2016 forward)

Imperva (NASDAQ:IMPV) Earnings History and Estimates Chart

Earnings by Quarter for Imperva (NASDAQ:IMPV)

Imperva (NASDAQ:IMPV) Earnings Estimates

2018 EPS Consensus Estimate: ($1.61)
2019 EPS Consensus Estimate: $0.63

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	1	($0.60)	($0.60)	($0.60)
Q2 2018	1	($0.51)	($0.51)	($0.51)
Q3 2018	1	($0.50)	($0.50)	($0.50)
Q1 2019	1	$0.02	$0.02	$0.02
Q2 2019	1	$0.10	$0.10	$0.10
Q3 2019	1	$0.19	$0.19	$0.19
Q4 2019	1	$0.32	$0.32	$0.32

Imperva (NASDAQ IMPV) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
5/2/2018	Q1 2018	$0.19	$0.26	$83.77 million	$84.24 million	View	N/A
2/8/2018	Q4 2017	$0.27	$0.40	$91.11 million	$91.10 million	View	Listen
11/8/2017	Q3 2017	$0.22	$0.33	$83.79 million	$83.89 million	View	N/A
7/27/2017	Q2 2017	$0.05	($0.10)	$74.30 million	$74.44 million	View	N/A
5/4/2017	Q1 2017	($0.62)	($0.29)	$68.16 million	$72.31 million	View	Listen
2/8/2017	Q416	$0.03	$0.32	$70.22 million	$78.40 million	View	Listen
11/3/2016	Q316	($0.16)	$0.08	$63.10 million	$68.40 million	View	Listen
8/4/2016	Q216	($0.04)	($0.23)	$66.06 million	$57.87 million	View	Listen
5/5/2016	Q116	($0.28)	($0.25)	$59.65 million	$59.80 million	View	Listen
2/3/2016	Q415	$0.15	$0.20	$68.11 million	$72.70 million	View	Listen
10/29/2015	Q3	($0.05)	$0.19	$56.52 million	$63.30 million	View	Listen
8/6/2015	Q215	($0.21)	($0.08)	$48.40 million	$53.50 million	View	Listen
5/7/2015	Q115	($0.38)	($0.26)	$40.50 million	$44.80 million	View	Listen
2/5/2015	Q414	($0.04)	($0.04)	$49.80 million	$51.40 million	View	Listen
10/30/2014	Q314	($0.63)	($0.51)	$40.00 million	$42.70 million	View	Listen
7/31/2014	Q2 2014	($0.72)	($0.59)		$38.44 million	View	N/A
5/1/2014	Q114	($0.41)	($0.36)	$31.73 million	$31.50 million	View	Listen
2/6/2014	Q413	$0.11	$0.12	$41.63 million	$42.70 million	View	Listen
11/5/2013	Q313	($0.05)	($0.01)	$34.43 million	$35.10 million	View	Listen
8/7/2013	Q2 2013	($0.05)	($0.10)	$31.38 million	$31.30 million	View	Listen
5/2/2013	Q1 2013	($0.10)	($0.13)	$27.49 million	$28.60 million	View	Listen
2/7/2013	Q4 2012	$0.02	$0.06	$29.91 million	$31.80 million	View	Listen
11/1/2012	Q3 2012	($0.07)	($0.08)			View	N/A
8/9/2012		($0.05)	($0.02)			View	N/A
5/3/2012		($0.13)	($0.12)			View	N/A
2/9/2012		($0.15)	($0.05)			View	N/A

(Earnings results data provided by Zacks Investment Research)

Imperva (NASDAQ:IMPV) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date

(Data available from 1/1/2013 forward)

Imperva (NASDAQ IMPV) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.10%

Insider Trading History for Imperva (NASDAQ:IMPV)

Institutional Ownership by Quarter for Imperva (NASDAQ:IMPV)

Imperva (NASDAQ IMPV) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/20/2018	Anthony J Bettencourt	Director	Sell	66,037	$46.98	$3,102,418.26	66,037
2/20/2018	Michael D Mooney	CRO	Sell	24,454	$47.18	$1,153,739.72	24,454
8/24/2017	Anthony J Bettencourt	Director	Sell	99,598	$43.59	$4,341,476.82	99,598
5/16/2017	Sunil D Nagdev	SVP	Sell	4,857	$49.00	$237,993.00	16,290
5/15/2017	Amichai Shulman	Insider	Sell	3,089	$48.70	$150,434.30	100,151
5/10/2017	Michael D Mooney	CRO	Sell	52,356	$47.51	$2,487,433.56	52,356
4/17/2017	Amichai Shulman	Insider	Sell	3,085	$41.97	$129,477.45	99,151
3/15/2017	Amichai Shulman	Insider	Sell	3,085	$41.85	$129,107.25	99,151
2/28/2017	Mark E Kraynak	SVP	Sell	45,314	$41.63	$1,886,421.82	10,064
2/21/2017	Anthony J Bettencourt	Chairman	Sell	84,863	$45.55	$3,865,509.65	84,863
2/21/2017	Terrence J Schmid	CFO	Sell	4,500	$45.53	$204,885.00	432
2/16/2017	Mark E Kraynak	SVP	Sell	1,731	$46.10	$79,799.10	3,858
2/15/2017	Amichai Shulman	Insider	Sell	3,085	$45.91	$141,632.35	95,713
1/17/2017	Amichai Shulman	CTO	Sell	3,085	$40.60	$125,251.00
12/21/2016	Amichai Shulman	Insider	Sell	3,085	$40.00	$123,400.00	91,830
11/16/2016	Mark E Kraynak	SVP	Sell	3,332	$40.16	$133,813.12	448
11/15/2016	Amichai Shulman	Insider	Sell	3,085	$40.10	$123,708.50	92,000
10/17/2016	Amichai Shulman	Insider	Sell	3,085	$48.57	$149,838.45	91,062
10/3/2016	Amichai Shulman	Insider	Sell	938	$53.27	$49,967.26	95,085
9/23/2016	Amichai Shulman	Insider	Sell	937	$51.00	$47,787.00	95,084
9/23/2016	Mark E. Kraynak	SVP	Sell	5,582	$51.00	$284,682.00
9/15/2016	Amichai Shulman	Insider	Sell	3,085	$44.30	$136,665.50	94,147
8/16/2016	Mark E Kraynak	SVP	Sell	2,614	$47.73	$124,766.22	3,552
8/15/2016	Amichai Shulman	Insider	Sell	3,085	$46.87	$144,593.95	94,317
7/27/2016	Amichai Shulman	Insider	Sell	3,085	$46.28	$142,773.80	93,380
7/26/2016	Mark E Kraynak	SVP	Sell	2,967	$46.15	$136,927.05	2,968
6/23/2016	Shlomo Kramer	Major Shareholder	Sell	75,000	$45.12	$3,384,000.00	1,304,521
6/20/2016	Shlomo Kramer	Major Shareholder	Sell	75,000	$40.24	$3,018,000.00	1,304,521
5/31/2016	Terrence J Schmid	CFO	Sell	5,000	$37.66	$188,300.00	335
5/25/2016	Anthony J Bettencourt	CEO	Sell	50,000	$36.15	$1,807,500.00	52,938
5/19/2016	Shlomo Kramer	Major Shareholder	Sell	50,000	$34.20	$1,710,000.00	1,304,521
5/17/2016	Shlomo Kramer	Major Shareholder	Sell	75,000	$33.95	$2,546,250.00	1,304,521
5/16/2016	Terrence J Schmid	CFO	Sell	7,000	$33.99	$237,930.00	8,053
5/12/2016	Shlomo Kramer	Major Shareholder	Sell	75,000	$34.16	$2,562,000.00	1,304,521
3/31/2016	Mark E. Kraynak	SVP	Sell	2,758	$50.00	$137,900.00
3/1/2016	Amichai Shulman	CTO	Sell	3,000	$45.25	$135,750.00	89,527
2/24/2016	Terrence J Schmid	CFO	Sell	6,500	$41.82	$271,830.00	7,468
2/17/2016	Mark E Kraynak	SVP	Sell	2,758	$40.04	$110,430.32	2,758
2/8/2016	Albert A Pimentel	Director	Buy	5,000	$38.93	$194,650.00	4,475
2/8/2016	Amichai Shulman	CTO	Sell	4,150	$38.12	$158,198.00	82,590
2/1/2016	Amichai Shulman	CTO	Sell	3,000	$50.49	$151,470.00	86,740
1/4/2016	Amichai Shulman	CTO	Sell	5,812	$60.36	$350,812.32	86,740
12/1/2015	Amichai Shulman	CTO	Sell	3,000	$74.22	$222,660.00	86,740
11/19/2015	Mark E. Kraynak	insider	Sell	10,000	$75.00	$750,000.00
11/19/2015	Tram T. Phi	VP	Sell	1,244	$73.26	$91,135.44	5,975
11/16/2015	Anthony J. Bettencourt	CEO	Sell	50,000	$69.33	$3,466,500.00	8,489
11/16/2015	Mark E. Kraynak	insider	Sell	3,789	$68.73	$260,417.97
11/12/2015	Shlomo Kramer	Major Shareholder	Sell	100,000	$71.65	$7,165,000.00	1,259,521
11/6/2015	Shlomo Kramer	Major Shareholder	Sell	50,000	$72.14	$3,607,000.00	1,259,521
11/4/2015	Shlomo Kramer	Major Shareholder	Sell	25,000	$72.05	$1,801,250.00	1,259,521
11/4/2015	Terrence J. Schmid	CFO	Sell	938	$71.14	$66,729.32
11/3/2015	Shlomo Kramer	Major Shareholder	Sell	25,000	$72.55	$1,813,750.00	1,259,521
10/1/2015	Amichai Shulman	CTO	Sell	2,813	$65.00	$182,845.00	84,802
8/31/2015	Terrence J. Schmid	CFO	Sell	1,595	$61.56	$98,188.20
8/17/2015	Mark E Kraynak	Insider	Sell	1,520	$71.42	$108,558.40
7/23/2015	Amichai Shulman	CTO	Sell	9,000	$70.00	$630,000.00
5/11/2015	Amichai Shulman	CTO	Sell	10,313	$51.09	$526,891.17
5/11/2015	Mark E Kraynak	Insider	Sell	4,000	$55.00	$220,000.00
4/20/2015	Mark E Kraynak	Insider	Sell	3,000	$47.53	$142,590.00
1/20/2015	Mark E Kraynak	Insider	Sell	3,000	$44.60	$133,800.00
1/8/2015	Amichai Shulman	CTO	Sell	1,875	$50.00	$93,750.00
12/16/2014	Amichai Shulman	CTO	Sell	9,492	$50.00	$474,600.00
12/15/2014	Amichai Shulman	CTO	Sell	11,133	$50.00	$556,650.00
12/1/2014	Amichai Shulman	CTO	Sell	5,000	$42.44	$212,200.00
11/28/2014	Yaniv Shaya	VP	Sell	2,512	$44.00	$110,528.00
11/20/2014	Mark E Kraynak	Insider	Sell	6,140	$42.00	$257,880.00
11/14/2014	Yaniv Shaya	VP	Sell	20,938	$44.52	$932,159.76
11/13/2014	Mark E Kraynak	Insider	Sell	2,000	$45.00	$90,000.00
11/11/2014	Tram T Phi	VP	Sell	10,076	$43.50	$438,306.00
11/4/2014	Terrence J Schmid	CFO	Sell	20,000	$40.73	$814,600.00
11/3/2014	Amichai Shulman	CTO	Sell	5,000	$41.09	$205,450.00
10/31/2014	Amichai Shulman	CTO	Sell	7,500	$36.56	$274,200.00
10/31/2014	Mark E Kraynak	Insider	Sell	2,000	$36.56	$73,120.00
10/6/2014	Amichai Shulman	CTO	Sell	2,500	$30.00	$75,000.00
9/2/2014	Amichai Shulman	CTO	Sell	5,000	$30.00	$150,000.00
8/21/2014	Terrence J Schmid	CFO	Sell	15,000	$29.07	$436,050.00
5/23/2014	Ralph Pisani	VP	Sell	8,613	$21.31	$183,543.03
5/21/2014	Terrence Schmid	CFO	Sell	15,000	$21.26	$318,900.00	2,853
4/7/2014	Shlomo Kramer	CEO	Sell	60,000	$50.53	$3,031,800.00	1,229,521
4/2/2014	Shlomo Kramer	CEO	Sell	40,000	$55.67	$2,226,800.00	1,229,521
1/8/2014	Shlomo Kramer	CEO	Sell	20,000	$50.10	$1,002,000.00	1,219,521
1/7/2014	Shlomo Kramer	CEO	Sell	40,000	$49.99	$1,999,600.00	1,219,521
1/3/2014	Shlomo Kramer	CEO	Sell	40,000	$48.31	$1,932,400.00	1,219,521
1/2/2014	Amichai Shulman	CTO	Sell	22,875	$47.68	$1,090,680.00	10,000
12/17/2013	Amichai Shulman	CTO	Sell	10,090	$45.00	$454,050.00	10,000
12/2/2013	Amichai Shulman	CTO	Sell	12,410	$44.13	$547,653.30	10,000
11/26/2013	Yaniv Shaya	VP	Sell	5,243	$43.92	$230,272.56	5,000
11/21/2013	Jason Forget	SVP	Sell	8,558	$38.98	$333,590.84
11/21/2013	Terrence Schmid	CFO	Sell	11,100	$40.26	$446,886.00
11/21/2013	Tram Phi	VP	Sell	6,646	$39.50	$262,517.00
11/19/2013	Mark Kraynak	VP	Sell	3,190	$37.80	$120,582.00	15,000
8/29/2013	Yaniv Shaya	VP	Sell	4,375	$48.00	$210,000.00
8/26/2013	Jason Forget	SVP	Sell	2,500	$47.50	$118,750.00
8/26/2013	Yaniv Shaya	VP	Sell	5,000	$47.71	$238,550.00
8/23/2013	Terrence Schmid	CFO	Sell	2,539	$47.20	$119,840.80
8/21/2013	Jason Forget	SVP	Sell	2,500	$47.00	$117,500.00
8/20/2013	Terrence Schmid	CFO	Sell	10,461	$47.03	$491,980.83
8/16/2013	Jason Forget	SVP	Sell	2,062	$47.00	$96,914.00
8/14/2013	Tram Phi	VP	Sell	5,000	$46.00	$230,000.00
8/13/2013	Jason Forget	SVP	Sell	2,000	$45.01	$90,020.00
8/13/2013	Mark Kraynak	VP	Sell	10,000	$44.41	$444,100.00	15,000
8/5/2013	Amichai Shulman	CTO	Sell	1,086	$52.58	$57,101.88
8/2/2013	Amichai Shulman	CTO	Sell	46,140	$51.87	$2,393,281.80
7/3/2013	Amichai Shulman	CTO	Sell	3,222	$45.21	$145,666.62
7/1/2013	Amichai Shulman	CTO	Sell	16,778	$44.94	$754,003.32
6/3/2013	Amichai Shulman	CTO	Sell	20,000	$39.49	$789,800.00
5/30/2013	Amichai Shulman	CTO	Sell	10,000	$39.93	$399,300.00
5/30/2013	Yaniv Shaya	VP	Sell	4,375	$40.40	$176,750.00
5/29/2013	Amichai Shulman	CTO	Sell	20,000	$39.96	$799,200.00
5/28/2013	Tram T Phi	VP	Sell	5,000	$40.25	$201,250.00
5/24/2013	Yaniv Shaya	VP	Sell	2,250	$40.00	$90,000.00
5/14/2013	Yaniv Shaya	VP	Sell	10,000	$39.00	$390,000.00
5/13/2013	Albert A Pimentel	Director	Sell	10,000	$37.93	$379,300.00
5/13/2013	Ralph Pisani	VP	Sell	5,000	$38.46	$192,300.00
5/13/2013	Terrence J Schmid	CFO	Sell	13,000	$37.75	$490,750.00
5/8/2013	Jason Forget	SVP	Sell	4,063	$37.31	$151,590.53
3/26/2013	Amichai Shulman	CTO	Sell	20,000	$38.30	$766,000.00
2/26/2013	Amichai Shulman	CTO	Sell	20,000	$36.05	$721,000.00
12/28/2012	Amichai Shulman	CTO	Sell	10,000	$31.01	$310,100.00
12/27/2012	Amichai Shulman	CTO	Sell	20,000	$30.98	$619,600.00
12/5/2012	Michael Boodaei	Director	Sell	30,000	$31.48	$944,400.00
11/27/2012	Amichai Shulman	CTO	Sell	20,000	$29.06	$581,200.00
11/7/2012	James R Tolonen	Director	Buy	5,000	$31.17	$155,850.00
11/1/2012	Amichai Shulman	CTO	Sell	20,000	$31.71	$634,200.00
10/4/2012	Michael Boodaei	Director	Sell	30,000	$34.03	$1,020,900.00
9/5/2012	Michael Boodaei	Director	Sell	20,000	$30.35	$607,000.00

(Data available from 1/1/2013 forward)

Imperva (NASDAQ IMPV) News Headlines

Source:

Date	Headline
	Imperva Announces First Quarter 2018 Financial Results finance.yahoo.com - April 26 at 4:43 PM
	Imperva (IMPV) option implied volatility elevated into EPS and outlook www.streetinsider.com - April 25 at 9:07 AM
	Imperva (IMPV) Scheduled to Post Quarterly Earnings on Wednesday www.americanbankingnews.com - April 25 at 3:16 AM
	Imperva (IMPV) Receives Buy Rating from Royal Bank of Canada www.americanbankingnews.com - April 23 at 6:30 AM
	Imperva (IMPV) Downgraded by ValuEngine to Sell www.americanbankingnews.com - April 19 at 2:58 PM
	Imperva Inc (IMPV) Given Consensus Recommendation of "Hold" by Brokerages www.americanbankingnews.com - April 18 at 7:24 PM
	Imperva (IMPV) Lifted to "Buy" at BidaskClub www.americanbankingnews.com - April 17 at 9:57 AM
	$84.16 Million in Sales Expected for Imperva Inc (IMPV) This Quarter www.americanbankingnews.com - April 17 at 5:01 AM
	Imperva (IMPV) Stock Rating Lowered by BidaskClub www.americanbankingnews.com - April 16 at 9:48 AM
	Zacks: Analysts Anticipate Imperva Inc (IMPV) Will Post Earnings of $0.19 Per Share www.americanbankingnews.com - April 15 at 1:17 AM
	North American Database Security Market Report 2018 - Data Privacy Laws are Driving the Market www.prnewswire.com - April 13 at 4:47 PM
	Analysts Set Expectations for Imperva Inc's Q1 2019 Earnings (IMPV) www.americanbankingnews.com - April 13 at 9:31 AM
	DA Davidson Offers 4 Reasons To Like Imperva www.msn.com - April 12 at 9:54 AM
	DA Davidson starts Imperva at 27% upside seekingalpha.com - April 12 at 9:54 AM
	Imperva Appoints David Woodcock to Lead Worldwide Sales finance.yahoo.com - April 11 at 4:47 PM
	Imperva (IMPV) Downgraded by Zacks Investment Research www.americanbankingnews.com - April 11 at 9:52 AM
	Evercore ISI Reiterates "$56.00" Price Target for Imperva (IMPV) www.americanbankingnews.com - April 10 at 8:54 PM
	Imperva (IMPV) Coverage Initiated at DA Davidson www.americanbankingnews.com - April 10 at 5:02 PM
	Imperva (IMPV) Upgraded to Hold by BidaskClub www.americanbankingnews.com - April 9 at 12:59 AM
	Imperva (IMPV) Downgraded by William Blair to "Market Perform" www.americanbankingnews.com - April 7 at 6:04 PM
	Imperva (IMPV) PT Lowered to $50.00 at Imperial Capital www.americanbankingnews.com - April 7 at 4:58 PM
	Piper Jaffray Downgrades Imperva (IMPV) to Neutral www.americanbankingnews.com - April 7 at 12:26 PM
	What Are Analysts Saying About The Future Of Imperva Inc’s (NASDAQ:IMPV)? finance.yahoo.com - April 4 at 9:14 AM
	Stifel Nicolaus Reaffirms Hold Rating for Imperva (IMPV) www.americanbankingnews.com - March 31 at 7:10 PM
	Imperva's (IMPV) "Underweight" Rating Reaffirmed at Morgan Stanley www.americanbankingnews.com - March 31 at 5:28 PM
	Imperva Inc (IMPV) Expected to Announce Quarterly Sales of $84.18 Million www.americanbankingnews.com - March 31 at 4:36 AM
	Imperva Inc (IMPV) Short Interest Update www.americanbankingnews.com - March 30 at 3:38 AM
	Imperva (IMPV) Rating Lowered to Hold at Zacks Investment Research www.americanbankingnews.com - March 29 at 7:58 PM
	BidaskClub Lowers Imperva (IMPV) to Hold www.americanbankingnews.com - March 29 at 11:28 AM
	$0.19 EPS Expected for Imperva Inc (IMPV) This Quarter www.americanbankingnews.com - March 29 at 5:16 AM
	Imperva (IMPV) Shares Cross Below 200 DMA www.nasdaq.com - March 28 at 9:20 AM
	Imperva (IMPV) Stock Rating Upgraded by BidaskClub www.americanbankingnews.com - March 25 at 9:31 AM
	Imperva Inc (IMPV) Given Consensus Recommendation of "Buy" by Brokerages www.americanbankingnews.com - March 24 at 7:32 PM
	4 Cyber-Security Stocks in Focus Post Expedia-Orbitz Hack finance.yahoo.com - March 23 at 4:49 PM
	Imperva Inc (IMPV) Holdings Lifted by Sei Investments Co. www.americanbankingnews.com - March 6 at 7:24 AM
	Imperva (IMPV) Rating Lowered to Sell at ValuEngine www.americanbankingnews.com - March 4 at 4:28 PM
	First Trust Advisors LP Has $9.24 Million Position in Imperva Inc (IMPV) www.americanbankingnews.com - March 4 at 9:50 AM
	Spark Investment Management LLC Takes Position in Imperva Inc (IMPV) www.americanbankingnews.com - March 2 at 12:29 PM
	Imperva Inc (IMPV) Receives Consensus Recommendation of "Buy" from Brokerages www.americanbankingnews.com - February 27 at 9:30 PM
	Carillon Tower Advisers Inc. Invests $36.80 Million in Imperva Inc (IMPV) www.americanbankingnews.com - February 27 at 5:32 AM
	Brokerages Expect Imperva Inc (IMPV) Will Post Quarterly Sales of $84.18 Million www.americanbankingnews.com - February 25 at 9:52 AM
	Imperva Inc (IMPV) CRO Sells $1,153,739.72 in Stock www.americanbankingnews.com - February 22 at 6:32 PM
	Imperva Inc (IMPV) Director Anthony J. Bettencourt Sells 66,037 Shares www.americanbankingnews.com - February 22 at 6:14 PM
	Imperva Announces Transition of Its Chairman of the Board finance.yahoo.com - February 21 at 4:55 PM
	Imperva (IMPV) Upgraded to Hold by ValuEngine www.americanbankingnews.com - February 17 at 6:34 PM
	Imperva (IMPV) Upgraded to "Strong-Buy" by Zacks Investment Research www.americanbankingnews.com - February 17 at 6:00 PM
	BRIEF-Elliott Reports Combined Economic Exposure Of About 6 Pct In Imperva www.reuters.com - February 15 at 8:31 AM
	Imperva Target of Unusually High Options Trading (IMPV) www.americanbankingnews.com - February 15 at 6:38 AM
	Traders Purchase High Volume of Call Options on Imperva (IMPV) www.americanbankingnews.com - February 14 at 8:44 PM
	Imperva Protects NetRefer Website and Customers From Cyberattacks finance.yahoo.com - February 13 at 9:29 AM

Imperva (NASDAQ:IMPV) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

Imperva (NASDAQ:IMPV) Income Statement, Balance Sheet and Cash Flow Statement

Imperva (NASDAQ IMPV) Stock Chart for Friday, April, 27, 2018

Loading chart…

This page was last updated on 4/27/2018 by MarketBeat.com Staff